BP Stock Price Today: Shares Rise as Oil Rebounds, Climate Challenge Adds Fresh Pressure

March 11, 2026
BP Stock Price Today: Shares Rise as Oil Rebounds, Climate Challenge Adds Fresh Pressure

London, March 11, 2026, 13:10 GMT

BP traded higher in London Wednesday, ticking up 1.15% to 505.3, per Reuters market data—though the move followed Brent crude’s return above $90 a barrel. The uptick had a catch: activist group Follow This threatened court action if BP fails to share a climate disclosure proposal before the April 23 shareholder meeting.

This has real weight for BP right now, with a management change looming. Meg O’Neill is set to step in come April, following BP’s February decision to pause buybacks in order to trim debt. That move has put a sharper spotlight on oil price volatility and whether the company’s pivot back to oil and gas will actually move the needle on returns for shareholders.

The wager hasn’t delivered across the board. Reuters noted on March 9 that crude was up more than 40% since Feb. 28. BP shares managed a 7.8% climb, outpacing Shell at 4.9% and Exxon’s barely-there 0.9%. Still, all three trailed the oil rally by a wide margin.

James West, head of energy and power research over at Melius Research, said the market is betting on a quick resolution to the Strait of Hormuz shutdown. For his part, David Hewitt at Hewitt Energy Perspectives pointed out this isn’t new territory—oil stocks have decoupled from crude before, once traders decide the disruption won’t drag on.

BP is once again facing pressure from governance activists. Follow This says investors representing around 1 trillion euros in assets have supported a proposal urging BP to detail its strategy for managing a prolonged decline in oil and gas demand. BP responded that, based on legal counsel, the proposal didn’t satisfy the necessary requirements and left it out of the annual meeting notice. The group warned it would pursue injunctive relief within two days unless BP agrees to include it.

The dispute surfaces just as BP shakes up its top ranks. Chairman Albert Manifold, speaking last week, pointed to a smaller board as the route to “faster decision-making and sharper oversight.” In April, O’Neill steps in—BP’s first outside hire for chief executive in over 100 years. Reuters

The rebound looks shaky. Oil tumbled over 11% Tuesday after President Donald Trump floated the idea that tensions in the Middle East might cool. Add to that: the International Energy Agency is weighing a potential 400 million-barrel drawdown from strategic reserves—the biggest on record. All of this throws BP’s recent gains into question, since any drop in crude could quickly erase its short-term boost.

BP’s shares are tracking oil prices closely, and the legal timeline isn’t far from mind. Investors are eyeing Brent’s ability to stick above $90, waiting to see if Follow This takes further steps before the April 23 meeting, and weighing how O’Neill will juggle debt reduction against shareholder payouts now that buybacks are on pause.

Stock Market Today

  • Ondine Biomedical Advances Light-Based Infection Control on FTSE AIM UK
    April 27, 2026, 4:36 AM EDT. Ondine Biomedical focuses on light-based infection control technology and is listed on the FTSE AIM UK market. The company's approach targets reducing infections through innovative light therapies, a sector gaining attention amid rising antimicrobial resistance concerns. Ondine's market presence reflects growing investor interest in specialized medical technologies that offer alternatives to traditional antibiotics. Their positioning in the AIM market highlights a strategic effort to leverage evolving healthcare needs and innovations in infection prevention solutions. This development underscores a shift towards non-drug interventions in tackling infections, positioning Ondine as a notable player in the biomedicine space.